Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

被引:94
作者
Buck, Marcia L.
Wiggins, Barbara S.
Sesler, Jefferson M.
机构
[1] Univ Virginia, Dept Pharm Serv, Hlth Syst, Charlottesville, VA 22908 USA
[2] Univ Virginia, Hlth Syst, Dept Internal Med, Div Cardiol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Hlth Syst, Dept Pharm Serv, Charlottesville, VA 22908 USA
关键词
cardiopulmonary resuscitation; intraosseous infusions;
D O I
10.1345/aph.1K168
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review and assess the available literature on the use of intraosseous (10) drug administration during cardiopulmonary resuscitation, addressing the benefits and risks of using this method of drug delivery in children and adults. DATA SOURCES: The MEDLINE (1950-July 2007) database was searched for pertinent abstracts, using the key term intraosseous infusions. Additional references were obtained from the bibliographies of the articles reviewed. Manufacturer Web sites were used to obtain information about 10 insertion devices. STUDY SELECTION AND DATA EXTRACTION: All available English-language clinical trials, retrospective studies, and review articles describing 10 drug administration were reviewed. Studies conducted in animal models to evaluate the effectiveness and safety of 10 drug administration were also included. DATA SYNTHESIS: 10 access uses the highly vascularized bone marrow to deliver fluids and medications during cardiopulmonary resuscitation. This route developed in the 1940s, has been revived in the past decade as a means of achieving rapid vascular access when intravenous access cannot be obtained. The primary advantage of 10 access is the high success rate (approximately 80%). Most trained providers can place an 10 line within 1-2 minutes. A number of small-scale studies and retrospective reviews have established the usefulness of this route for the delivery of many commonly used resuscitation drugs. In addition, animal models have demonstrated rapid drug delivery to the systemic circulation, While all resuscitation drugs can be given by the 10 route, administration of ceftriaxone, chloramphenicol, phenytoin, tobramycin, and vancomycin may result in lower peak serum concentrations. The most common adverse effect seen with 10 use, extravasation, has been reported in 12% of patients. Compartment syndrome, osteomyelitis, and tibial fracture are rare, but have also been reported. CONCLUSIONS: 10 administration is a safe and effective method for delivering drugs during cardiopulmonary resuscitation. It should be considered whenever intravenous access cannot be rapidly obtained.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 47 条
  • [1] *AHA, 2006, PEDIATRICS, V117, P1005
  • [2] Banerjee S, 1994, Indian Pediatr, V31, P1511
  • [3] EMERGENCY INFUSION OF CATECHOLAMINES INTO BONE-MARROW
    BERG, RA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1984, 138 (09): : 810 - 811
  • [4] INTRAOSSEOUS INFUSION OF DOBUTAMINE AND ISOPROTERENOL
    BILELLO, JF
    OHAIR, KC
    KIRBY, WC
    MOORE, JW
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1991, 145 (02): : 165 - 167
  • [5] Tibial fracture as a complication of intraosseous infusion during pediatric resuscitation
    Bowley, DMG
    Loveland, J
    Pitcher, GJ
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 55 (04): : 786 - 787
  • [6] INTRAVASCULAR ACCESS IN PEDIATRIC CARDIAC-ARREST
    BRUNETTE, DD
    FISCHER, R
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1988, 6 (06) : 577 - 579
  • [7] Pharmacokinetic longitudinal studies of antibiotics administered via a permanent intraosseous device in micropigs
    Chastagner, P
    Lozniewski, A
    Lascombes, P
    Barberi-Heyob, M
    Merthes, PM
    Merlin, JL
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (06): : 635 - 640
  • [8] Long-term effects on tibial growth after intraosseous infusion: A prospective, radiographic analysis
    Claudet, I
    Baunin, C
    Laporte-Turpin, E
    Marcoux, MO
    Grouteau, E
    Cahuzac, JP
    [J]. PEDIATRIC EMERGENCY CARE, 2003, 19 (06) : 397 - 401
  • [9] Davidoff Jack, 2005, JEMS, V30, P20
  • [10] Drinker CK, 1922, AM J PHYSIOL, V62, P1